Evaluation of MRI cytometry parameters improves diagnostic accuracy for ovarian lesions and epithelial ovarian cancers, suggesting enhanced treatment guidance.
Motivation: Preoperative differentiation between benign ovarian lesions and epithelial ovarian cancers (EOCs), and further subclassification type I and II EOCs, is essential for guiding treatment. Goal(s): To evaluate MRI cytometry-derived microstructural parameters for noninvasive differentiating benign ovarian lesions and EOCs, and between type I and II EOCs. Approach: MRI cytometry extracted microstructural parameters, including diameter, intracellular volume fraction, cellularity and extracellular diffusivity. Diagnostic abilities were evaluated using unpaired two-tailed t-tests, linear regression, AUC, sensitivity and specificity. Results: Microstructural parameters showed significant differences and strong diagnostic performance for distinguishing benign ovarian lesions from EOCs and differentiating type I and II EOCs. Impact: For the first time, MRI cytometry demonstrated high feasibility and diagnostic accuracy for non-invasively distinguishing benign ovarian lesions from epithelial ovarian cancers (EOCs) and further differentiating between type I and II EOCs.
No takes yet. Share an insight, caveat, or question.
Yue et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: